Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Non–small cell lung cancer
DS Ettinger, W Akerley, G Bepler, MG Blum… - Journal of the national …, 2010 - jnccn.org
Overview Lung cancer is the leading cause of cancer-related death in the United States. An
estimated 219,440 new cases (116,090 men; 103,350 women) of lung and bronchus cancer …
estimated 219,440 new cases (116,090 men; 103,350 women) of lung and bronchus cancer …
Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo‐based photon and electron external beam treatment planning
The Monte Carlo (MC) method has been shown through many research studies to calculate
accurate dose distributions for clinical radiotherapy, particularly in heterogeneous patient …
accurate dose distributions for clinical radiotherapy, particularly in heterogeneous patient …
Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1
X Li, L Duan, S Yuan, X Zhuang, T Qiao, J He - Journal of inflammation, 2019 - Springer
Background Radiation-induced lung fibrosis (RILF) is a severe and life-threatening
complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a …
complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a …
[HTML][HTML] Heart dose is an independent dosimetric predictor of overall survival in locally advanced non–small cell lung cancer
CK Speirs, TA DeWees, S Rehman… - Journal of Thoracic …, 2017 - Elsevier
Introduction In the randomized trial of standard-versus high-dose chemoradiotherapy for
locally advanced (LA) NSCLC (Radiation Therapy Oncology Group 0617), overall survival …
locally advanced (LA) NSCLC (Radiation Therapy Oncology Group 0617), overall survival …
Stereotactic body radiotherapy (SBRT) for operable stage I non–small-cell lung cancer: can SBRT be comparable to surgery?
PURPOSE: To review treatment outcomes for stereotactic body radiotherapy (SBRT) in
medically operable patients with Stage I non–small-cell lung cancer (NSCLC), using a …
medically operable patients with Stage I non–small-cell lung cancer (NSCLC), using a …
[HTML][HTML] Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: a secondary analysis of …
Simple Summary Emerging evidence indicates that the immune system plays an important
role in controlling tumors during radiotherapy, and radiation-induced immune toxicity such …
role in controlling tumors during radiotherapy, and radiation-induced immune toxicity such …
Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non–small-cell lung cancer: A phase 2 …
Importance Our previous studies demonstrated that tumors significantly decrease in size and
metabolic activity after delivery of 45 Gy of fractionated radiatiotherapy (RT), and that …
metabolic activity after delivery of 45 Gy of fractionated radiatiotherapy (RT), and that …
Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy
C Park, L Papiez, S Zhang, M Story… - International Journal of …, 2008 - Elsevier
PURPOSE: Overprediction of the potency and toxicity of high-dose ablative radiotherapy
such as stereotactic body radiotherapy (SBRT) by the linear quadratic (LQ) model led to …
such as stereotactic body radiotherapy (SBRT) by the linear quadratic (LQ) model led to …
Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and …
PURPOSE: To compare dose volume histograms of intensity-modulated proton therapy
(IMPT) with those of intensity-modulated radiation therapy (IMRT) and passive scattering …
(IMPT) with those of intensity-modulated radiation therapy (IMRT) and passive scattering …
Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications
A Chi, Z Liao, NP Nguyen, J Xu, B Stea… - Radiotherapy and …, 2010 - Elsevier
PURPOSE: To analyze the patterns of failure, the toxicity profile, and the factors influencing
efficacy of stereotactic body radiation (SBRT) for early-stage non-small-cell lung cancer …
efficacy of stereotactic body radiation (SBRT) for early-stage non-small-cell lung cancer …